3 documents found, page 1 of 1
The HepHIV 2023 Madrid conference: A call to action for political leadership in...
Simões, D; Raben, D; Moran, AB; Imaz, A; Stengaard, AR; Raahauge, A; Sullivan, AK; Vaughan, E; Brännström, J; De Baetselier, I; Platteau, T; Casabona, JIntroduction and Objectives: The HepHIV 2023 Conference, held in Madrid in November 2023, highlighted how Europe is not on track to meet the United Nations (UN) sustainable development goals and Joint UN Programme on HIV/AIDS (UNAIDS) targets. This article presents the outcomes of the conference, which focus on ways to improve testing and linkage to care for HIV, viral hepatitis, and other sexually transmitted ...
A call to action to reclaim focus on testing and early treatment for HIV, viral...
Stengaard, AR; Raben, D; Leite, RB; Seyler, T; Lazarus, JV; Lambert, J; Collins, B; Attawell, K; Raahauge, A; Rockstroh, JK; Simões, DWe present the outcomes of the HepHIV 2021 Lisbon & virtual conference held on 5-7 May 2021, including a Call to Action addressing policy and practice implications in the field of earlier and integrated testing for HIV, viral hepatitis, STI and TB and in light of lessons learned from the COVID-19 pandemic. Conference presentations showed that combination prevention and integrated testing and care models for mul...
Increasing integrated testing in community settings through interventions for c...
Gasbarrini, N; Dubravić, D; Combs, L; Dišković, A; Ankiersztejn-Bartczak, M; Colaiaco, F; Wawer, I; Wysocki, P; Rosińska, M; Marzec-Boguslawska, ABackground: Maximising access to testing by targeting more than one infection is effective in identifying new infections in settings or populations. Within the EU funded Joint Action INTEGRATE, this paper examined the feasibility and impact of expanding integrated testing for HIV, hepatitis C (HCV), chlamydia, gonorrhoea and/or syphilis in four community-based pilots through targeted interventions in Croatia, I...